The researchers, whose study is published in Pharmacological Research, identified the smallest part of a peptide (small protein ... delivered a significant reduction in the severity of psoriasis, that ...

For example, the small-molecule inhibitor zasocitinib (formerly TAK-279) produced a PASI 75 response rate of 67-68% after 12 weeks in a phase II trial of patients with moderate or severe psoriasis, ...

Many psoriasis drugs under investigation are biologics similar to current biologics—which are therapies that come from living organisms—but there’s also some exciting research into small molecules and ...

Scientists have shown that a sequence of just three amino acids may reduce the severity of psoriasis, when applied topically in an emollient cream.

Discover the latest drugs and treatment options in the Psoriasis Pipeline. Dive into DelveInsight's comprehensive report ...

A decade-long study finds that obesity is associated with a significantly increased risk for biologic treatment failure in ...

2025 — People with the skin condition psoriasis often have invisible inflammation in the small intestine with an increased propensity for 'leaky gut', according to new research. These changes in ...

Hartman says that doctors often can confirm psoriasis visually. They may send a small patch of skin for laboratory review, too. From there, your doctor can determine if you have psoriasis and what ...

The psoriasis pipeline possesses some drugs in mid- and late-stage development to be approved in the near future. The emerging landscape holds a dive ...

Psoriasis shows on the skin, but it's a disease which goes a lot deeper and is linked to serious health problems. In recent years, newer targeted drugs are making a difference.